Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Clin Exp Pharmacol Physiol. 2012 Oct;39(10):858–863. doi: 10.1111/1440-1681.12001

Fig. 1.

Fig. 1

Effects of aldosterone and p21 siRNA on senescence-associated β-galactosidase staining (A-G), and levels of p21 mRNA (H) and protein (I) in human proximal tubular cells at 3 and 5 days after aldosterone treatment. Data are expressed as means ± S.E.M.; n = 6 per group. *P < 0.05, **P < 0.01, compared to the same-day aldosterone-treatment group.